SCHEMBL9795280

SCHEMBL9795280

CC(O)CC(=O)NCCN

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GABRR1 P24046 2/20 0.37
PDK2 Q15119 1/20 0.36
HPGD P15428 2/20 0.34
KMT2A Q03164 2/20 0.34
PAOX Q6QHF9 2/20 0.33
MEN1 O00255 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TERT O14746 2/20 0.33
PSMB5 P28074 1/20 0.33
CYP1A2 P05177 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505848 0.84 SMN1; SMN2 (0.52) ALDH1A1TP53SMN1; SMN2GABRR1HPGD
SCHEMBL20581925 0.82 ALDH1A1 (0.50) ALDH1A1TP53SMN1; SMN2HPGDKMT2A
SCHEMBL20581926 0.82 ALDH1A1 (0.50) ALDH1A1TP53SMN1; SMN2HPGDKMT2A
SCHEMBL22929128 0.81 TP53 (0.37) ALDH1A1TP53SMN1; SMN2GABRR1PDK2
SCHEMBL21888407 0.81 GABRR1 (0.50) ALDH1A1TP53SMN1; SMN2GABRR1HPGD
SCHEMBL5907647 0.80 ALDH1A1 (0.48) ALDH1A1TP53SMN1; SMN2KMT2AMEN1
SCHEMBL14984047 0.80 ALDH1A1 (0.50) ALDH1A1TP53SMN1; SMN2HPGDKMT2A
SCHEMBL3831548 0.80 ALDH1A1 (0.48) ALDH1A1TP53SMN1; SMN2KMT2AMEN1
SCHEMBL20670296 0.79 TP53 (0.36) ALDH1A1TP53SMN1; SMN2GABRR1PDK2
SCHEMBL10594782 0.79 ALDH1A1 (0.77) ALDH1A1GABRR1PDK2HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5037849-A For treatment of heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1991-08-06 US disclosed
EP-0200915-B1 AMINOPROPANOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND MEDICINES CONTAINING THEM Roche Diagnostics GmbH (DE) 1989-09-27 EP disclosed
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 EP disclosed